0001179110-13-002018.txt : 20130206
0001179110-13-002018.hdr.sgml : 20130206
20130206162728
ACCESSION NUMBER: 0001179110-13-002018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130204
FILED AS OF DATE: 20130206
DATE AS OF CHANGE: 20130206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gestin Denis M
CENTRAL INDEX KEY: 0001423587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12441
FILM NUMBER: 13578190
MAIL ADDRESS:
STREET 1: ONE LILLEHEI PLAZA
CITY: ST. PAUL
STATE: MN
ZIP: 55117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ST JUDE MEDICAL INC
CENTRAL INDEX KEY: 0000203077
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411276891
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE ST JUDE MEDICAL DRIVE
CITY: ST PAUL
STATE: MN
ZIP: 55117
BUSINESS PHONE: 6517562000
MAIL ADDRESS:
STREET 1: ONE ST JUDE MEDICAL DRIVE
CITY: ST PAUL
STATE: MN
ZIP: 55117
4
1
edgar.xml
FORM 4 -
X0306
4
2013-02-04
0
0000203077
ST JUDE MEDICAL INC
STJ
0001423587
Gestin Denis M
ONE ST. JUDE MEDICAL DRIVE
ST PAUL
MN
55117
0
1
0
0
President, Int'l Division
Common Stock
2013-02-04
4
M
0
37120
30.58
A
42712
D
Common Stock
2013-02-04
4
S
0
37120
41.0686
D
5592
D
Common Stock
2013-02-05
4
M
0
52880
30.58
A
58472
D
Common Stock
2013-02-05
4
S
0
52880
41.4905
D
5592
D
Stock Option (Right to Buy)
30.58
2013-02-04
4
M
0
37120
0
D
2009-12-15
2016-12-15
Common Stock
90000
52880
D
Stock Option (Right to Buy)
30.58
2013-02-05
4
M
0
52880
0
D
2009-12-15
2016-12-15
Common Stock
52880
0
D
The price in Column 4 is a weighted average. The prices actually received ranged from $41.03 to $41.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average. The prices actually received ranged from $41.42 to $41.5201. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The option shares vested 25% on each of the first four anniversary dates of the date of the grant beginning the date shown and became fully vested on December 15, 2012.
/s/ Kashif Rashid, Attorney in Fact
2013-02-06